
NRC Health rose 65.8% from $16.02 to $26.56, ahead of the S&P 500's +13.3%. Its worst day was Feb 3 (−19.5%), and its low came Feb 17 at $12.03.
Nov 17, 2025 – Nov 13, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $0.16 was reported on $35.2M revenue.
−19.5%, the year's worst day · S&P 500 −0.8%
NRC Health closed at its lowest level of the year, 24.9% below where the year started.
Story events cover the past 12 months · Times ET
−0.4% · S&P 500 +0.2%
EPS of $0.21 was reported on $34.8M revenue.
−1.8% · S&P 500 0.0%
NRC Health shares fell 11.7%, while the S&P 500 rose 1.7%.
−11.7% · S&P 500 +1.7%
EPS of $0.31 beat the $0.14 estimate on $35.4M revenue (est. $34.9M).
−18.1% · S&P 500 −1.5%
EPS of $0.21 beat the $0.21 estimate on $38.4M revenue (est. $35.8M).
+7.9% · S&P 500 +0.3%
Where it ended: a close of $26.56 on Nov 13, 2026. Up next: Q4 2026 earnings on Feb 2, 2027 (EPS est. $0.24, revenue est. $38.4M).
As of the Nov 13, 2026 close
Replay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NRC and SPY from Benzinga historical bars. Not investment advice.